Lynn Seely

Companies

• AbCellera Biologics Inc.Board member Jul 6, 2026 to now¹
• Lyell Immunopharma, Inc.Chief executive officer Dec 19, 2022 to now²
• Lyell Immunopharma, Inc.President Dec 19, 2022 to now²
• Lyell Immunopharma, Inc.Board member Jun 16, 2021 to now³
• Blueprint Medicines CorpBoard member Apr 15, 2016 to now⁴
• Myovant Sciences Ltd.Board member Oct 26, 2016 to Apr 7, 2020⁵
• Myovant Sciences Ltd.Principal Executive Officer Oct 26, 2016 to Apr 7, 2020⁵
• MedivationChief Medical Officer Mar 20, 2007 to Feb 18, 2015⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• LILyell Immunopharma, Inc. LYEL63,899 shares⁷$523.3K at $8.19Aug 21, 2026
• BMBlueprint Medicines Corp0 shares⁸Jul 17, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 21, 2026Sold 9,589 shares at $15.54 of Lyell Immunopharma, Inc.⁷
• Aug 10, 2026Sold 390 shares at $14.34 of Lyell Immunopharma, Inc.⁹
• May 11, 2026Sold 388 shares at $18.91 of Lyell Immunopharma, Inc.¹⁰
• Feb 11, 2026Sold 7,455 shares at $23.39 of Lyell Immunopharma, Inc.¹¹
• Feb 10, 2026Sold 438 shares at $23.12 of Lyell Immunopharma, Inc.¹²
• Feb 9, 2026Granted 20,000 shares of Lyell Immunopharma, Inc.¹²
• Nov 10, 2025Sold 412 shares at $16.11 of Lyell Immunopharma, Inc.¹³
• Aug 21, 2025Sold 7,257 shares at $10.54 of Lyell Immunopharma, Inc.¹⁴
• Aug 20, 2025Granted 40,000 shares of Lyell Immunopharma, Inc.¹⁴
• Aug 12, 2025Sold 406 shares at $10.34 of Lyell Immunopharma, Inc.¹⁵
• Aug 11, 2025Sold 391 shares at $10.53 of Lyell Immunopharma, Inc.¹⁵
• Jul 17, 2025U 13,254 shares of Blueprint Medicines Corp⁸
• Jul 17, 2025Returned to company 3,902 shares of Blueprint Medicines Corp⁸
• Jun 18, 2025Granted 3,902 shares at $128.12 of Blueprint Medicines Corp¹⁶
• Mar 14, 2025Bought 175,000 shares at $0.61 of Lyell Immunopharma, Inc.¹⁷
• Feb 10, 2025Granted 337,500 shares of Lyell Immunopharma, Inc.¹⁸
• Jun 12, 2024Granted 2,242 shares of Blueprint Medicines Corp¹⁹
• Feb 9, 2024Granted 200,000 shares of Lyell Immunopharma, Inc.²⁰
• Jun 21, 2023Granted 2,600 shares of Blueprint Medicines Corp²¹
• Jun 21, 2022Granted 2,600 shares of Blueprint Medicines Corp²²